MaxCyte (MXCT) has released an update.
MaxCyte Inc., a leader in cell-engineering platform technologies, has announced the issuance of 228,807 new shares of common stock following the exercise of share options and vesting of restricted stock units. As of July 31, 2024, the company’s total issued stock capital is 105,052,931 shares. This update provides shareholders with the denominator needed to calculate changes in their shareholding interests.
For further insights into MXCT stock, check out TipRanks’ Stock Analysis page.
